null (NUREXONE BIOLOGIC INC) aksje
NRXBF
$0.4600-0.0133 (-2.81%)
Laster graf...
NUREXONE BIOLOGIC INC
Market Cap
$42,341,092
Åpning0.4600
Høy0.4600
Lav0.4600
Volum2k
P/EN/A
Markedsverdi42.34M
52-ukers høy0.8000
52-ukers lav0.4085
Gj.sn. volum6.55k
UtbytteN/A
Beta0.32
EPS-0.0800
Om null (NUREXONE BIOLOGIC INC) aksje
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toronto, Canada.
Selskapsinformasjon
Børs: OTC Markets OTCQB (OQB)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
1 Adelaide Street East
M5C 2V9 Toronto, Canada
M5C 2V9 Toronto, Canada
Nettside: https://nurexone.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
3.50
↑ 660.9%
Gjennomsnittlig kursmål
3.50
↑ 660.9%
Median kursmål
3.50
↑ 660.9%
Høyeste kursmål
3.50
↑ 660.9%